pinealon peptide nasal spray

Pinealon peptide nasal spray formulations represent an accessible research tool for investigating short synthetic bioregulators within Central Nervous System (CNS) and cellular aging models. Designed exclusively for preclinical in vitro and in vivo laboratory research, this short tripeptide (Glu-Asp-Arg) is evaluated for its direct interaction with chromatin and neuronal defense mechanisms.

GMP-compliant U.S. facilities
ISO 17025 third-party COAs
100% domestic — no imports
Fast tracked domestic shipping
Shop research peptides

Quick answer

Pinealon peptide nasal spray formulations represent an accessible research tool for investigating short synthetic bioregulators within Central Nervous System (CNS) and cellular aging models. Designed exclusively for preclinical in vitro and in vivo laboratory research, this short tripeptide (Glu-Asp-Arg) is evaluated for its direct interaction with chromatin and neuronal defense mechanisms.

Reviewed by PX1 Research scientific team

Key takeaways

  • A pinealon peptide nasal spray solution is a specialized laboratory vehicle designed to deliver the synthetic tripeptide Glu-Asp-Arg (EDR) into non-invasive mucosal exposure models.
  • Pinealon is a short-chain peptide composed of three amino acid residues: L-glutamyl-L-aspartyl-L-arginine (sequence: H-Glu-Asp-Arg-OH).
  • The primary mechanism of action associated with Pinealon centers on epigenetic regulation.
  • Neuronal cultures subjected to chemical ischemia, hydrogen peroxide exposure, or glutamate excitotoxicity are frequently utilized to evaluate Pinealon's neuroprotective parameters.

Pinealon Peptide Nasal Spray in Laboratory Research

A pinealon peptide nasal spray solution is a specialized laboratory vehicle designed to deliver the synthetic tripeptide Glu-Asp-Arg (EDR) into non-invasive mucosal exposure models. Preclinical studies suggest that intranasal administration pathways allow small bioregulatory peptides to bypass the blood-brain barrier (BBB) via olfactory and trigeminal neuronal networks, making this delivery method a focal point for neurobiological and pharmacological assays.

In academic and institutional settings, Pinealon is classified within the broader family of peptide bioregulators. It is investigated primarily for its capacity to modulate gene expression, reduce intracellular accumulation of reactive oxygen species (ROS), and preserve functional cellular architecture under condition-induced metabolic or hypoxic stress. All research formulations are synthesized strictly for laboratory evaluation and in vitro analytical procedures.

Chemical Profile and Molecular Structure of Glu-Asp-Arg

Pinealon is a short-chain peptide composed of three amino acid residues: L-glutamyl-L-aspartyl-L-arginine (sequence: H-Glu-Asp-Arg-OH). With a molecular formula of C15H26N6O8 and a low molecular weight of approximately 418.4 g/mol, its simple structural footprint facilitates direct cellular penetration and nuclear translocation.

Because of its minimal steric hindrance, the Glu-Asp-Arg tripeptide can interact directly with specific nucleotide sequences in double-stranded DNA. In cell-free and cell-culture models, researchers utilize the Pinealon Nasal Spray baseline chemical structure to study sequence-specific binding within the promoter regions of genes governing oxidative balance, apoptosis, and protein synthesis.

Epigenetic Regulation and Gene Expression Mechanisms

The primary mechanism of action associated with Pinealon centers on epigenetic regulation. In vitro data indicate that short peptide bioregulators bind to hydrogen bonds within the major and minor grooves of DNA, inducing local conformational shifts that alter histone acetylation and transcription factor accessibility.

Preclinical models evaluating epigenetic peptide mechanisms demonstrate that Pinealon upregulates expression of endogenous antioxidant enzymes, including superoxide dismutase (SOD) and glutathione peroxidase (GPx). Furthermore, assays involving aged or senescent cell lines show modified expression of heat shock proteins (HSPs), indicating a protective transcriptional response against protein denaturation and cellular aging markers.

Neuronal Stress, ROS, and Cellular Defense Models

Neuronal cultures subjected to chemical ischemia, hydrogen peroxide exposure, or glutamate excitotoxicity are frequently utilized to evaluate Pinealon's neuroprotective parameters. In these models, treatment with Glu-Asp-Arg correlates with decreased markers of lipid peroxidation and stabilized mitochondrial membrane potential.

Preclinical rodent models have further evaluated how intranasal delivery of short tripeptides modulates microglial activation and cytokine production. Data published in neuroprotective research studies suggest that Pinealon administration mitigates hyper-inflammatory signaling cascades, maintaining structural integrity in cerebral cortex and hippocampal tissues following acute stress exposures.

Comparative Analysis: Pinealon vs. Epitalon, Semax, and Selank

To understand where Pinealon fits within neuropeptide and bioregulator science, researchers often compare its activity to other short-chain peptide compounds. While Pinealon (Glu-Asp-Arg) targets specific transcriptional pathways linked to cortical cell defense, Epitalon (Ala-Glu-Asp-Gly) is predominantly investigated for its influence on telomerase activity and pineal gland regulation. Both compounds belong to the Khavinson bioregulator class, utilizing short sequences to modulate chromatin access.

In contrast, synthetic neuropeptides such as Semax and Selank function via distinct neurotrophic and neuromodulatory pathways. Semax is widely studied for stimulating Brain-Derived Neurotrophic Factor (BDNF) and nerve growth factor (NGF) synthesis, whereas Selank acts primarily on GABAergic neurotransmission and enkephalin degradation enzymes. Evaluating these distinct mechanism profiles across our complete catalog of research peptides enables laboratories to select the exact molecular candidate required for their specific neurological or epigenetic models.

Intranasal Delivery Mechanics in Preclinical Models

Intranasal administration protocols in preclinical rodent studies present distinct advantages over systemic parenteral routes. By delivering compounds across the nasal respiratory and olfactory epithelia, researchers can achieve targeted CNS bioavailability while minimizing systemic enzymatic degradation by hepatic and intestinal proteases.

Laboratory studies measuring the pharmacokinetics of intranasally delivered tripeptides demonstrate rapid diffusion through extracellular pathways surrounding olfactory nerves into the cerebrospinal fluid (CSF). This route makes a calibrated intranasal solution an ideal delivery platform for evaluating acute physiological responses in neuropeptide research.

Analytical Standards, Testing, and Quality Verification

Reliable preclinical outcomes depend entirely on the purity, stability, and chemical consistency of the experimental compound. PX1 Research enforces rigorous quality assurance protocols to ensure every batch of Pinealon meets strict analytical criteria:

1. High-Performance Liquid Chromatography (RP-HPLC): Confirms chemical purity levels exceeding 98.0%, verifying the absence of truncated peptide fragments or synthesis byproducts. 2. Mass Spectrometry (ESI-MS): Validates exact molecular weight and structural identity against theoretical benchmarks. 3. Endotoxin Testing (LAL Assay): Guarantees endotoxin levels remain below stringent institutional limits (<0.05 EU/mg) to prevent non-specific immune activation in culture assays. 4. Analytical Traceability: Every lot is manufactured in US-based, GMP-compliant facilities and verified by independent ISO 17025 accredited laboratories, complete with a batch-specific Certificate of Analysis (COA).

Reconstitution, Buffer Selection, and Laboratory Storage

When handling raw peptide powder or preparing standardized intranasal solutions, researchers must adhere to strict aseptic laboratory procedures. Lyophilized Pinealon powder should be stored at -20°C in a desiccated environment to maintain long-term stability and prevent moisture absorption.

For aqueous reconstitution, sterile bacteriostatic water or phosphate-buffered saline (PBS, pH 7.4) is recommended depending on the requirements of the biological assay. Once dissolved into a liquid intranasal delivery format, solutions must be kept refrigerated at 2°C to 8°C and utilized within a designated experimental timeframe to avoid hydrolysis or peptide aggregation. Repeated freeze-thaw cycles must be strictly avoided.

Institutional Procurement and Supply Chain Integrity

PX1 Research serves as a trusted domestic supplier for academic institutions, biotechnology enterprises, and contract research organizations (CROs). All orders are fulfilled directly from our centralized logistics centers in California and Arizona, providing same-day dispatch for orders finalized Monday through Friday before 12:00 PM PST.

Laboratories conducting high-throughput screening or multi-phase animal studies can establish streamlined procurement via our bulk lab account services. Every shipment is packaged with thermal protective measures and full batch documentation to ensure strict chain-of-custody and compound integrity upon arrival.

Frequently Asked Questions

What is a pinealon peptide nasal spray formulation used for in research?

A pinealon peptide nasal spray formulation is used in preclinical research to investigate non-invasive mucosal delivery of the synthetic tripeptide Glu-Asp-Arg. Investigators utilize this model to study blood-brain barrier bypass pathways, epigenetic gene regulation, and neuronal oxidative stress responses in laboratory environments.

What is the amino acid sequence of Pinealon?

Pinealon is a synthetic tripeptide consisting of L-glutamyl-L-aspartyl-L-arginine, abbreviated as Glu-Asp-Arg or EDR.

How does Pinealon interact with cellular DNA in vitro?

In vitro studies indicate that Pinealon binds to specific double-stranded DNA sequences within gene promoter regions, modifying chromatin condensation and regulating transcription of enzymes responsible for cellular defense and antioxidant responses.

Why is intranasal administration preferred in rodent neuropeptide models?

Intranasal delivery bypasses hepatic first-pass metabolism and direct enzymatic degradation in the gastrointestinal tract, allowing direct transport of small peptides along olfactory and trigeminal nerve pathways into the central nervous system.

What purity levels are guaranteed for PX1 Research peptides?

PX1 Research guarantees a minimum chemical purity of 98.0% for all research peptides, verified through Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) and Mass Spectrometry (MS).

How should reconstituted Pinealon nasal spray solutions be stored?

Reconstituted liquid solutions should be stored under refrigeration at 2°C to 8°C and protected from light. Aliquoting is recommended to prevent degradation caused by repeated temperature fluctuations.

What is the difference between Pinealon and Epitalon?

Pinealon is a tripeptide (Glu-Asp-Arg) focused primarily on cortical neuronal protection and gene expression, whereas Epitalon is a tetrapeptide (Ala-Glu-Asp-Gly) investigated for telomerase induction and pineal gland bioregulation.

Are PX1 Research products tested for bacterial endotoxins?

Yes. Every batch undergoes Limulus Amebocyte Lysate (LAL) endotoxin testing in an ISO 17025 accredited laboratory to verify that endotoxin levels meet strict research thresholds (<0.05 EU/mg).

Where are PX1 Research peptide products manufactured and shipped from?

All PX1 Research compounds are manufactured in US-based GMP-compliant facilities and shipped directly from state-of-the-art dispatch centers located in California and Arizona.

Can universities and corporate laboratories set up wholesale accounts?

Yes, verified academic institutions, CROs, and corporate research facilities can access specialized tiered pricing and bulk supply agreements through the PX1 Research wholesale portal.

Related pages

All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.